FDA: Bristol HIV drug carries liver risks; Novo posts higher sales, static profits;

  @FiercePharma: Pharmalot: Cephalon Discloses Payments to Doctors. Article | Follow @FiercePharma

> Federal health officials said patients taking the Bristol-Myers Squibb HIV drug Videx are at risk of a rare, but potentially fatal, liver disorder. Release | Report

> Danish drugmaker Novo Nordisk said fourth-quarter profits remained almost unchanged as a 4 percent growth in sales was offset by higher costs. Report

> Allergan said U.S. regulators have approved Juvederm XC, a new version of its Juvederm wrinkle filler. Report

> Pfizer reports its Q4 and full-year results tomorrow, while GlaxoSmithKline plans to report on Thursday. Report | Release

> Resverlogix, a small Canadian biotech company, named Bayer HealthCare CEO Arthur Higgins to its board of directors. Report

Biotech News

 @FierceBiotech:  Reuters: FDA to review Teva biosimilar of Amgen's Neupogen. Article | Follow @FierceBiotech

 @JohnCFierce: It didn't take long for the Acorda buyout talk to get started this morning. Follow John on Twitter

> There's plenty of buzz out there in advance of Ironwood's big IPO, and it isn't all pretty. Story

> FDA OKs Onyx's blockbuster Ph III cancer trial. Report

> Wooed by the prospects of one of Pierre Fabre's promising pre-clinical cancer programs, Abbott Laboratories has agreed to pay the French biotech $25 million upfront, two years of research expenses and an undisclosed slate of milestones to buy its way into a worldwide licensing pact. Item

> Spectrum Pharmaceuticals is paying $30 million down and up to $320 million in cash and a million shares of stock for a significant share of the worldwide rights to a late-stage cancer compound advanced by TopoTarget A/S. Story

Biotech Research News

> Israel's Compugen saw its stock price shoot up 17 percent this morning on the news that it has discovered and completed early validation work on a promising protein that could prove an effective therapy for autoimmune diseases. Report

> The NIH is slated for a modest 3.2 percent budget hike for the next fiscal year in President Obama's newly proposed budget. Story

> In experiments published recently in Proceedings of the National Academy of Sciences and Brain Behavior and Immunity, researchers showed that dendritic cells native to the brain can muster the immune system's soldier T cells when confronted by certain threats. Item

Pharma Manufacturing News

> Drugs finished second--behind food and feed, but ahead of new cigarette and tobacco controls--in funding requests in the FDA's 2011 budget request. Story

> GMP consultants working for Caraco have put the finishing touches on a work plan that will let the drugmaker resume manufacturing at its Michigan facilities. The company now awaits FDA approval of the plan, in accordance with its consent decree. Story

> California, Florida, Texas, Georgia, Illinois and New Jersey are the top states for number of cargo thefts. Report

And Finally... Fish oil may work to head off the first psychotic episode among young people at high risk of developing mental illness. Report